BeOne Medicines (BEIGF) Interest Expenses (2015 - 2026)
BeOne Medicines (BEIGF) reported Interest Expenses of $32.9 million for Q1 2026, up 369.68% year-over-year from $7.0 million in Q1 2025, and up 369.68% quarter-over-quarter from $7.0 million in Q1 2025.
BeOne Medicines (BEIGF) Interest Expenses (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 4 years of Interest Expenses data on file, last reported at $32.9 million in Q1 2026.
- Interest Expenses for Q1 2026 came in at $32.9 million, up 369.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.9 million (up 369.68% YoY), and the FY2025 annual result was $58.2 million, up 167.07% from the prior year.
- Interest Expenses climbed to $32.9 million in Q1 2026 per BEIGF's latest filing, from $7.0 million in the prior quarter.
- Over five years, Interest Expenses peaked at $32.9 million in Q1 2026 and troughed at $7.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -5.58 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 32.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.89 Mn |
| Mar 31, 2026 | 32.89 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Sep 30, 2016 | 284,000.00 |
| Sep 30, 2016 | 284,000.00 |
| Jun 30, 2016 | 141,000.00 |
| Jun 30, 2016 | 141,000.00 |
| Mar 31, 2016 | 204,000.00 |
| Mar 31, 2016 | 204,000.00 |
| Sep 30, 2015 | 300,000.00 |
| Sep 30, 2015 | 300,000.00 |
| Jun 30, 2015 | 273,000.00 |
| Jun 30, 2015 | 273,000.00 |
| Mar 31, 2015 | 267,000.00 |
| Mar 31, 2015 | 267,000.00 |